Top Markets
Coin of the day
BioAge Labs Inc. BioAge Labs Inc.

BioAge Labs Inc.

BIOA
Rangering i aksjer #15401
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops... BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Aksjekurs
$9.50
Markedsverdi
$357.48M
Endring (1 dag)
-0.05%
Endring (1 år)
92.60%
Land
US
Handel BioAge Labs Inc. (BIOA)

Kategori

Aksjeprishistorikk for BioAge Labs Inc. (BIOA)
Høyeste sluttskurs: $9.50 den 2026-09-01

Laveste sluttskurs: $20.04 den 2024-09-01
Aksjeprishistorikk for BioAge Labs Inc. fra 2024 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 19.87%
2025 48.86%
2024 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$548.98 40.40%
US
$1.03K 44.32%
NL
$121.37 -11.93%
AU
$144.39 499.38%
US
$748.60 4.92%
CH